Top Stories

Vericiguat (Verquvo) Cleared for Heart Failure in Europe

The European Commission (EC) has approved the use of vericiguat (Verquvo, Merck & Co) for treating symptomatic chronic heart failure with reduced …

Read more @ www.medscape.com

Back to top button